Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-11-028637
Filing Date
2011-03-24
Accepted
2011-03-24 15:57:48
Documents
8
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c13894e10vk.htm 10-K 1295789
2 EXHIBIT 10.19 c13894exv10w19.htm EX-10.19 14763
3 EXHIBIT 10.20 c13894exv10w20.htm EX-10.20 14966
4 EXHIBIT 21.1 c13894exv21w1.htm EX-21.1 1840
5 EXHIBIT 31.1 c13894exv31w1.htm EX-31.1 6119
6 EXHIBIT 31.2 c13894exv31w2.htm EX-31.2 6117
7 EXHIBIT 32.1 c13894exv32w1.htm EX-32.1 3484
8 EXHIBIT 32.2 c13894exv32w2.htm EX-32.2 3461
  Complete submission text file 0000950123-11-028637.txt   1347874
Mailing Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 415-283-2200
VIA Pharmaceuticals, Inc. (Filer) CIK: 0001003929 (see all company filings)

EIN.: 330687976 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27264 | Film No.: 11709366
SIC: 2836 Biological Products, (No Diagnostic Substances)